Cargando…
Circulating Tumor Cells for Glioma
Liquid biopsy has entered clinical applications for several cancers, including metastatic breast, prostate, and colorectal cancer for CTC enumeration and NSCLC for EGFR mutations in ctDNA, and has improved the individualized treatment of many cancers, but relatively little progress has been made in...
Autores principales: | Zhang, Huikai, Yuan, Fanen, Qi, Yangzhi, Liu, Baohui, Chen, Qianxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987781/ https://www.ncbi.nlm.nih.gov/pubmed/33777749 http://dx.doi.org/10.3389/fonc.2021.607150 |
Ejemplares similares
-
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2019) -
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2022) -
Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment
por: Xu, Yang, et al.
Publicado: (2021) -
Identifying circulating glioma cells and their clusters as diagnostic markers by a novel detection platform
por: Qi, Yangzhi, et al.
Publicado: (2021) -
RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway
por: Xu, Yang, et al.
Publicado: (2020)